Clinical Trial Update: Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of guselkumab in active psoriatic arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Psoriatic Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2020-10-14